Stay updated on Recombinant vs Marketed Flu Vaccines in Children Clinical Trial
Sign up to get notified when there's something new on the Recombinant vs Marketed Flu Vaccines in Children Clinical Trial page.

Latest updates to the Recombinant vs Marketed Flu Vaccines in Children Clinical Trial page
- Check2 days agoChange DetectedThe page’s footer “Revision” has been updated from v3.5.2 to v3.5.3, indicating a site/version release rather than a change to the study record itself.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedThe page revision metadata updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check53 days agoChange Detected- Revision added: v3.4.3; revision v3.4.2 removed.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed as a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no substantive changes to study content or layout are evident from the screenshot. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Recombinant vs Marketed Flu Vaccines in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Recombinant vs Marketed Flu Vaccines in Children Clinical Trial page.